Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Equity (2016 - 2026)

Neuroone Medical Technologies filings provide 13 years of Return on Equity readings, the most recent being 0.01% for Q1 2026.

  • On a quarterly basis, Return on Equity rose 2.0% to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 2.0% increase, with the full-year FY2025 number at 0.01%, up 3.0% from a year prior.
  • Return on Equity hit 0.01% in Q1 2026 for Neuroone Medical Technologies, down from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2025 to a low of 0.06% in Q3 2024.
  • Median Return on Equity over the past 5 years was 0.01% (2023), compared with a mean of 0.02%.
  • Biggest five-year swings in Return on Equity: decreased -4bps in 2024 and later increased 6bps in 2025.
  • Neuroone Medical Technologies' Return on Equity stood at 0.01% in 2022, then tumbled by -152bps to 0.03% in 2023, then crashed by -51bps to 0.04% in 2024, then surged by 74bps to 0.01% in 2025, then dropped by -11bps to 0.01% in 2026.
  • The last three reported values for Return on Equity were 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025) per Business Quant data.